Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ribosomal peptide, brevicidine. The engineered mimics show antimicrobial activities against pathogens susceptible to brevicidine, which demonstrate that conversion of NRPs to RiPPs is feasible and offer great opportunities for engineering a wide range of effective antibiotics.</p
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
This review compares structural features common to both nonribosomal and ribosomally synthesised and...
Bacterial secondary metabolites have historically been a rich source of antibiotic compounds. The ge...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
The excessive and inappropriate use of antibiotics has escalated antimicrobial resistance, driving t...
The excessive and inappropriate use of antibiotics has escalated antimicrobial resistance, driving t...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
This review compares structural features common to both nonribosomal and ribosomally synthesised and...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
This review compares structural features common to both nonribosomal and ribosomally synthesised and...
Bacterial secondary metabolites have historically been a rich source of antibiotic compounds. The ge...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
Zhao et al. describe a strategy to synthesize mimics of the recently discovered antimicrobial non-ri...
The excessive and inappropriate use of antibiotics has escalated antimicrobial resistance, driving t...
The excessive and inappropriate use of antibiotics has escalated antimicrobial resistance, driving t...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
This review compares structural features common to both nonribosomal and ribosomally synthesised and...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
This review compares structural features common to both nonribosomal and ribosomally synthesised and...
Bacterial secondary metabolites have historically been a rich source of antibiotic compounds. The ge...